These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 28360190)
1. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile. Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190 [TBL] [Abstract][Full Text] [Related]
2. Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer. Vermassen T; Van Praet C; Vanderschaeghe D; Maenhout T; Lumen N; Callewaert N; Hoebeke P; Van Belle S; Rottey S; Delanghe J Electrophoresis; 2014 Apr; 35(7):1017-24. PubMed ID: 24254641 [TBL] [Abstract][Full Text] [Related]
3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988 [TBL] [Abstract][Full Text] [Related]
4. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer. Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148 [TBL] [Abstract][Full Text] [Related]
5. Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer. Vermassen T; Van Praet C; Lumen N; Decaestecker K; Vanderschaeghe D; Callewaert N; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J Prostate; 2015 Feb; 75(3):314-22. PubMed ID: 25358590 [TBL] [Abstract][Full Text] [Related]
6. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone. Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843 [TBL] [Abstract][Full Text] [Related]
7. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer. Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861 [TBL] [Abstract][Full Text] [Related]
8. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen. Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397 [TBL] [Abstract][Full Text] [Related]
9. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962 [TBL] [Abstract][Full Text] [Related]
10. Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection. Ferrer-Batallé M; Llop E; Ramírez M; Aleixandre RN; Saez M; Comet J; de Llorens R; Peracaula R Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420168 [TBL] [Abstract][Full Text] [Related]
11. The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer. Wang M; Zou L; Liang J; Wang X; Zhang D; Fang Y; Zhang J; Xiao F; Liu M Med Sci Monit; 2018 May; 24():3034-3041. PubMed ID: 29741162 [TBL] [Abstract][Full Text] [Related]
12. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2-10 ng/mL at initial biopsy. He YD; Tao W; He T; Wang BY; Tang XM; Zhang LM; Wu ZQ; Deng WM; Zhang LX; Shao CK; Zhou J; Rong LM; Gao X; Li LY Mol Cancer; 2021 Jul; 20(1):96. PubMed ID: 34301266 [TBL] [Abstract][Full Text] [Related]
13. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns. Janković MM; Kosanović MM Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318 [TBL] [Abstract][Full Text] [Related]
14. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer. Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773 [No Abstract] [Full Text] [Related]
15. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis. Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428 [TBL] [Abstract][Full Text] [Related]
16. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335 [TBL] [Abstract][Full Text] [Related]
17. Detection of miRNAs in urine of prostate cancer patients. Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485 [TBL] [Abstract][Full Text] [Related]
18. Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis. Shin H; Park YH; Kim YG; Lee JY; Park J PLoS One; 2018; 13(3):e0194818. PubMed ID: 29584777 [TBL] [Abstract][Full Text] [Related]
19. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]